1. Pan American Health Organization (PAHO). Third Meeting of International Commission for Certification of Poliomyelitis Eradication. Washington: Expanded Program on Immunization, 1994.
2. Advisory Committee on Immunization Practices (ACIP). Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices. MMWR1997;46(RR-3):1–25.
3. Melnick JL. Advantages and disadvantages of killed and live poliomyelitis vaccines. Bull World Health Organ1978;56:21–38.
4. Friedrich F, Filippis AMB, Ferreira FC, Schatzmayer HG, Da Silva EE. Genomic characterization of type 1 Sabin-related polioviruses isolated in Brazil. Acta Virol1995;39:23–29.
5. Furione M, Guillot S, Otelea D, Balanant J, Candrea A, Crainic R. Polioviruses with natural recombinant isolated from vaccine-associated paralytic poliomyelitis. Virology1993;196:199–208.